High factor VIII (FVIII) levels in venous thromboembolism: role of unbound FVIII

Theoretically, von Willebrand factor (VWF) should be capable of binding all factor VIII (FVIII), but an unbound FVIII (uFVIII) plasma fraction remains. In patients' status post deep-vein thrombosis (DVT), an altered uFVIII fraction and high FVIII levels might be indicative of dysfunctional FVIII regulation. Out of 928 consecutive DVT patients, 321 were found to have high FVIII levels. After excluding 183 patients with known causes for high FVIII levels, plasma samples with unexplainably high FVIII levels were available from 84 patients. To capture the FVIII-VWF-complex, superparamagnetic polystyrene beads with covalently attached streptavidin were coated with biotinylated anti-rabbit Ig and incubated with rabbit anti-human VWF-Ig. Slowly thawed plasma samples were added to cooled beads, which were then separated by a magnetic particle concentrator. The uFVIII fraction was calculated by dividing the FVIII activity in the supernatant of the FVIII-VWF-complex-free sample by the FVIII activity in the supernatant of the control sample. Additionally, the VWF residuum in the supernatant was determined. Compared to age- and sex-matched blood donors, thrombosis patients showed a significantly higher plasma FVIII/VWF ratio (median: 1.3 vs. 1.0, p<0.001). uFVIII fraction data were adjusted for VWF residuum. After forward stepwise logistic regression, uFVIII had an odds ratio of 0.48 (95% CI 0.34-0.65), i.e. the uFVIII fraction was reduced in thrombosis patients. Analysis of covariance confirmed these results: In thrombosis patients, the estimated mean of the uFVIII fraction was significantly lower (6.34% vs. 7.58%, p<0.001). In conclusion, thrombosis patients with high FVIII levels showed a higher FVIII/VWF ratio, similar to mice with defective FVIII clearance. The clearly reduced uFVIII fraction lends further support to the hypothesis of a modified FVIII clearance.

[1]  J. Vandenbroucke,et al.  Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis , 1995, The Lancet.

[2]  J. Houwing-Duistermaat,et al.  Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia , 2000, British journal of haematology.

[3]  C. Schambeck,et al.  Venous Thromboembolism and Associated High Plasma Factor VIII Levels:Linked to Cytomegalovirus Infection? , 2000, Thrombosis and Haemostasis.

[4]  B. M. Taleghani,et al.  Familial Clustering of High Factor VIII Levels in Patients With Venous Thromboembolism , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[5]  S. Lethagen,et al.  Pharmacokinetics and hemostatic effect of different factor VIII/von Willebrand factor concentrates in von Willebrand's disease type III , 1992, Annals of Hematology.

[6]  F. Rosendaal,et al.  The Factor VIII/Von Willebrand Factor Ratio Discriminates between Reduced Synthesis and Increased Clearance of Von Willebrand Factor , 2002, Thrombosis and Haemostasis.

[7]  J. Vandenbroucke,et al.  The Leiden Thrombophilia Study (LETS) , 1997, Thrombosis and Haemostasis.

[8]  M. Laffan,et al.  Analysis of the F8 Gene in Individuals with High Plasma Factor VIII:C Levels and Associated Venous Thrombosis , 1998, Thrombosis and Haemostasis.

[9]  I. Sussman,et al.  Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. , 1977, The Journal of clinical investigation.

[10]  J. Vermylen,et al.  A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor. , 2000, Blood.

[11]  I. Mikhailenko,et al.  Role of the Low Density Lipoprotein-related Protein Receptor in Mediation of Factor VIII Catabolism* , 1999, The Journal of Biological Chemistry.

[12]  F. Rosendaal,et al.  High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene , 2001, British journal of haematology.

[13]  P. Lenting,et al.  Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency. , 2003, Blood.

[14]  Niels Bovenschen,et al.  Low Density Lipoprotein Receptor-related Protein and Factor IXa Share Structural Requirements for Binding to the A3 Domain of Coagulation Factor VIII* , 2003, The Journal of Biological Chemistry.

[15]  M Stain,et al.  High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. , 2000, The New England journal of medicine.

[16]  J. V. van Mourik,et al.  The Light Chain of Factor VIII Comprises a Binding Site for Low Density Lipoprotein Receptor-related Protein* , 1999, The Journal of Biological Chemistry.